- Home
- UBCP vs EQ Comparison
UBCP vs EQ Comparison
Compare UBCP & EQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | UBCP | EQ |
|---|---|---|
| Founded | 1902 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 80.3M | 89.4M |
| IPO Year | 1995 | 2018 |
Fundamental Metrics
Financial Performance| Metric | UBCP | EQ |
|---|---|---|
| Price | $14.43 | $1.39 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $8.56 |
| AVG Volume (30 Days) | 6.5K | ★ 439.5K |
| Earning Date | 11-13-2026 | 11-12-2026 |
| Dividend Yield | ★ 6.54% | N/A |
| EPS Growth | ★ 5.51 | N/A |
| EPS | ★ 0.69 | N/A |
| Revenue | N/A | ★ $41,095,000.00 |
| Revenue This Year | $2.21 | N/A |
| Revenue Next Year | $6.72 | N/A |
| P/E Ratio | $21.16 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.55 | $1.16 |
| 52 Week High | $17.34 | $6.20 |
Technical Indicators
Market Signals| Indicator | UBCP | EQ |
|---|---|---|
| Relative Strength Index (RSI) | 49.49 | 44.12 |
| Support Level | $13.37 | $1.30 |
| Resistance Level | $16.08 | $1.51 |
| Average True Range (ATR) | 0.56 | 0.13 |
| MACD | 0.12 | 0.04 |
| Stochastic Oscillator | 59.49 | 62.86 |
Price Performance
Historical ComparisonAbout UBCP United Bancorp Inc.
United Bancorp Inc operates as a bank holding company that provides commercial and retail banking services. Through its subsidiary (Unified Bank), the company provides a broad range of banking and financial services, which include accepting demand, savings, and time deposits and granting commercial, real estate, and consumer loans. The Company's primary deposit products are checking, savings, and term certificate accounts, and its primary lending products are residential mortgage, commercial, and installment loans. The bank also operates in Marshall County, West Virginia.
About EQ Equillium Inc.
Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.